Free Daily Podcast Summary
The Lancet in conversation with: Daily Summaries Delivered
by The Lancet Group
Get key takeaways, quotes, and insights from The Lancet in conversation with in a 5-minute read. Delivered straight to your inbox.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 2 weeks ago31 min
Can semaglutide be used to treat alcohol use disorder?
The Lancet’s Niall Boyce and Jonathan Pimm, and eBioMedicine’s Kalypso Karastergiou discuss an exciting new potential treatment for alcohol use disorder: semaglutide. As new research is published in The Lancet, they go behind the headlines with lead author Professor Anders Fink-Jensen to ask what the study showed, and what its implications are for the future of addiction medicine. Click here to read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00305-3/fulltext
- Feb 3, 202630 min
Louise Chappell and Na’ama Carlin on Personal Cancer Stories
The uniqueness of each patient is at the heart of this year's World Cancer Day. Each cancer patient has their own hopes, dreams and fears. In this Podcast you will hear from two cancer survivors about their unique experience with cancer and the importance of personalised cancer care not only on their bodies but also on their lives. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
- Dec 19, 202524 min
Susannah Stanway on the London Global Cancer Week
In Conversation with The Lancet returns with Dr Susannah Stanway, honorary consultant medical oncologist at the Royal Marsden and honorary clinical senior lecturer in Education at the Institute of Cancer Research, reflecting on London Global Cancer Week 2025. This episode goes beyond event highlights to discuss the need for a global oncology agenda rooted in equity, evidence-based care, and value across care settings. Topics span from geriatric oncology to cardio-oncology, nursing workforce resilience, cancer care in conflict zones, and sustainable health financing, showing how multi-stakeholder collaboration can drive policy and practical improvements, especially in low- and middle-income countries. Listeners will take away practical steps for action: integrating geriatric assessment and baseline cardiovascular risk checks, strengthening cancer registries and national audits, and pursuing domestic funding for universal health coverage. The discussion highlights the urgency of addressing cancer globally including context specific solutions sensitive to local settings and emphasises prevention, early diagnosis, and accessible treatment as core priorities. Click here to visit the London Global Cancer week website Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
- Dec 9, 20251h 1m
Carlos Monteiro, Camila Corvalán, and Phil Baker on Ultra-Processed Foods and Human Health
Ultra-processed foods are on the rise. Despite the emphasis placed on individual responsibility, our deteriorating diets are primarily the result of the sophisticated political tactics of a powerful global ultra-processed food industry. Addressing this urgent threat demands a coordinated response from the global public health community. So argues a 3-paper Series published in The Lancet that examines the evidence, proposes policies to halt and reverse the rise in ultra-processed foods, and illuminates the fundamental political and economic drivers at play. Professor Carlos Monterio, Professor Camila Corvalán, and Professor Phil Baker join host Callam Davidson to discuss this powerful and timely Series. Click here to visit the series hub: https://www.thelancet.com/series-do/ultra-processed-food Download the 'Lancet Series on Ultra-Processed Foods and Human Health' infographic here: https://www.thelancet.com/infographics-do/ultra-processed-food-2025 Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
- Dec 7, 202513 min
Presented at ASH: the EPCORE FL-1 study on epcoritamab in follicular lymphoma
Franck Morschhauser joins Ben Abbott of The Lancet to discuss the phase 3 EPCORE FL-1 study on epcoritamab, lenalidomide, and rituximab for relapsed or refractory follicular lymphoma, which is being presented at ASH 2025. Click here to read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02360-8/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
- Oct 19, 202520 min
Presented at ESMO: the HARMONi-6 study on a bispecific antibody therapy for squamous NSCLC
Shun Lu joins Ben Abbott of The Lancet to discuss the phase 3 HARMONi-6 trial of ivonescimab plus chemotherapy as first-line treatment in advanced squamous non-small-cell lung cancer, which is being presented at ESMO 2025. Click here to read the full article Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
- Oct 17, 202522 min
Presented at ESMO: the POTOMAC study on immunotherapy in non-muscle-invasive bladder cancer
Neal Shore joins Ben Abbott of The Lancet to discuss the phase 3 POTOMAC trial of durvalumab plus BCG in BCG-naïve, high-risk non-muscle-invasive bladder cancer, which is being presented at ESMO 2025. Click here to read the full article Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
- Jul 28, 202520 min
Stephen Chan on the Lancet Commission on addressing the global hepatocellular carcinoma burden
With the global burden of liver cancer growing, The Lancet has commissioned an international panel of experts to identify strategies to strengthen the prevention, surveillance, diagnosis, and treatment of liver cancer. Stephen Chan joins Ben Abbott of The Lancet to discuss the key messages of the Commission, which is published today on World Hepatitis Day. Read the full Commission: https://www.thelancet.com/commissions-do/hepatocellular-carcinoma?dgcid=buzzsprout_icw_podcast_lancethcc25_lancet Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Get The Lancet in conversation with summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
eClinicalMedicine in conversation with
The Lancet Group
The Lancet Healthy Longevity in conversation with
The Lancet Group
The Lancet HIV in conversation with
The Lancet Group
Journal of Clinical Oncology (JCO) Podcast
American Society of Clinical Oncology (ASCO)
Oncology Today with Dr Neil Love
Dr. Neil Love
Oncology News Central Peer-Spectives
Oncololgy News Central
Oncology News Central Peer-Spectives
Oncololgy News Central
Lung Cancer Update
Dr. Neil Love
Gastrointestinal Cancer Update
Dr. Neil Love
Breast Cancer Update
Dr. Neil Love
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
Decera Clinical Education Oncology Podcast
Decera Clinical Education
About The Lancet in conversation with
Jessamy Bagenal, Chloe Wilson, and Callum Davidson—editors at The Lancet—and Gavin Cleaver, The Lancet Group’s Audio Producer, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers topics that advance the field of medical research, from exploring treatments to examining drug trials, public health outbreaks to surgical techniques, and more.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from The Lancet in conversation with in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's The Lancet in conversation with daily summary?
It's a free AI-powered email that summarizes new episodes of The Lancet in conversation with as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the The Lancet in conversation with podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official The Lancet in conversation with product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by The Lancet Group.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does The Lancet in conversation with release new episodes?
The Lancet in conversation with publishes monthly. Our AI generates a summary within hours of each new episode.
What topics does The Lancet in conversation with cover?
The Lancet in conversation with covers topics including Science, Education, Medicine, Fitness, Health & Fitness, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting The Lancet in conversation with summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.